Charles Schwab’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.18M Buy
387,503
+20,954
+6% +$172K ﹤0.01% 2515
2025
Q1
$2.62M Buy
366,549
+16,819
+5% +$120K ﹤0.01% 2529
2024
Q4
$2.7M Sell
349,730
-68,009
-16% -$526K ﹤0.01% 2582
2024
Q3
$4.38M Buy
417,739
+37,055
+10% +$389K ﹤0.01% 2440
2024
Q2
$4.45M Buy
380,684
+37,069
+11% +$434K ﹤0.01% 2408
2024
Q1
$7.24M Buy
343,615
+16,164
+5% +$341K ﹤0.01% 2150
2023
Q4
$5.88M Buy
327,451
+1,683
+0.5% +$30.2K ﹤0.01% 2234
2023
Q3
$5.36M Buy
325,768
+27,590
+9% +$454K ﹤0.01% 2220
2023
Q2
$5.96M Buy
298,178
+8,571
+3% +$171K ﹤0.01% 2162
2023
Q1
$5.48M Buy
289,607
+2,040
+0.7% +$38.6K ﹤0.01% 2162
2022
Q4
$6.52M Buy
287,567
+8,739
+3% +$198K ﹤0.01% 2070
2022
Q3
$7.37M Buy
278,828
+4,431
+2% +$117K ﹤0.01% 2006
2022
Q2
$6.78M Sell
274,397
-12,889
-4% -$318K ﹤0.01% 2039
2022
Q1
$9.54M Sell
287,286
-952
-0.3% -$31.6K ﹤0.01% 1985
2021
Q4
$9.43M Buy
288,238
+3,538
+1% +$116K ﹤0.01% 2032
2021
Q3
$11.9M Buy
284,700
+19,471
+7% +$816K ﹤0.01% 1903
2021
Q2
$10.3M Buy
265,229
+19,407
+8% +$754K ﹤0.01% 1985
2021
Q1
$8.39M Buy
245,822
+39,328
+19% +$1.34M ﹤0.01% 2053
2020
Q4
$9.37M Buy
206,494
+2,625
+1% +$119K ﹤0.01% 1902
2020
Q3
$5.61M Sell
203,869
-11,948
-6% -$329K ﹤0.01% 2008
2020
Q2
$7.95M Buy
215,817
+12,857
+6% +$474K ﹤0.01% 1779
2020
Q1
$6.57M Buy
202,960
+5,784
+3% +$187K ﹤0.01% 1695
2019
Q4
$8.08M Buy
197,176
+4,483
+2% +$184K ﹤0.01% 1765
2019
Q3
$6.86M Buy
192,693
+6,869
+4% +$245K ﹤0.01% 1812
2019
Q2
$9.55M Sell
185,824
-23,384
-11% -$1.2M 0.01% 1617
2019
Q1
$12M Buy
209,208
+16,199
+8% +$928K 0.01% 1467
2018
Q4
$8.1M Buy
193,009
+6,494
+3% +$272K 0.01% 1599
2018
Q3
$14.1M Buy
186,515
+42,307
+29% +$3.19M 0.01% 1400
2018
Q2
$10.3M Buy
144,208
+9,114
+7% +$654K 0.01% 1585
2018
Q1
$4.03M Buy
135,094
+6,907
+5% +$206K ﹤0.01% 2051
2017
Q4
$4.26M Buy
128,187
+5,678
+5% +$189K ﹤0.01% 2002
2017
Q3
$4.04M Buy
122,509
+24,814
+25% +$818K ﹤0.01% 1990
2017
Q2
$1.93M Buy
97,695
+23,971
+33% +$474K ﹤0.01% 2233
2017
Q1
$1.42M Buy
73,724
+4,275
+6% +$82.5K ﹤0.01% 2308
2016
Q4
$1.29M Buy
69,449
+3,850
+6% +$71.5K ﹤0.01% 2351
2016
Q3
$920K Buy
65,599
+24,821
+61% +$348K ﹤0.01% 2427
2016
Q2
$327K Buy
40,778
+17,794
+77% +$143K ﹤0.01% 2750
2016
Q1
$249K Buy
22,984
+357
+2% +$3.87K ﹤0.01% 2830
2015
Q4
$376K Buy
+22,627
New +$376K ﹤0.01% 2768